TheStreet’s Action Alerts PLUS Portfolio Manager and host of CNBC’s ‘Mad Money‘ Jim Cramer talked about Procter & Gamble's (PG) earnings report when answering viewers questions from social media on Friday. Cramer said P&G's CEO is leaving and the organic growth there is nil, but P&G has a good dividend and the company has cut out a lot of fat. Cramer said he likes Procter only as a catch up trade, and added that Unilever (UN) is doing much better. A viewer wanted to know if Apple (AAPL) can do the same as Amazon (AMZN) and Google (GOOG) when it reports earnings next week. Cramer said the bar is high, but investors should own Apple and not trade it. Another viewer asked which stock is best positioned for growth, Johnson & Johnson (JNJ), Eli Lilly (LLY) or Gilead (GILD). Cramer said Lilly is his favorite right now because it has both an Alzheimer's and diabetes drug. He said JNJ has risen very nicely since its last quarter and it's become a 'darling' at $100. Cramer said Gilead will go higher. You can send Jim Cramer questions on Facebook and on Twitter, follow him @JimCramer and send questions using #CramerQ.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.